# Health Catalyst, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Health Catalyst, Inc.). ## Overview Health Catalyst builds cloud-based data and analytics software for healthcare organizations, combining a data platform, analytics applications, and implementation expertise. Its customers use the solution to integrate clinical and operational data, generate insights, and improve financial, operational, and care outcomes across health systems and related healthcare entities. ## Products & services • Cloud-based data and analytics platform • Analytics applications for clinical and operational improvement • Professional services and implementation support • Managed services and healthcare data expertise • Patient engagement and care coordination solutions - **Technology revenue** (67%) — Subscription and platform revenue from cloud data infrastructure and analytics applications, including Health Catalyst Ignite and related software. - **Professional services revenue** (33%) — Implementation, advisory, and managed services that help clients deploy the platform and realize measurable improvement. - Cloud-based data and analytics platform - Analytics applications for clinical and operational improvement - Professional services and implementation support - Managed services and healthcare data expertise - Patient engagement and care coordination solutions ## Customers Health Catalyst sells primarily to healthcare providers, especially health systems that need to unify data and improve clinical, financial, and operational performance. It also serves risk-bearing entities, life science organizations, payers, and some healthcare technology companies, with patient engagement and care coordination offerings broadening the addressable market. - **Health systems and healthcare providers** (primary) — Primary buyers of the platform and applications to manage data, improve workflows, and drive measurable clinical and financial outcomes. - **Risk-bearing entities** (secondary) — Organizations that need population health, care coordination, and analytics to manage utilization and downside risk. - **Life science organizations** (secondary) — Buy data and analytics capabilities for research, registry, and evidence-generation use cases. - **Payers** (secondary) — Use selected analytics and data tools to support cost, quality, and utilization management. - **Healthcare technology companies** (emerging) — Purchase cybersecurity or data-related solutions in narrower use cases. - Health systems buying analytics to improve care and operating performance - Risk-bearing entities needing population health and cost management tools - Healthcare providers seeking data integration and reporting modernization - Life science organizations using healthcare data and analytics capabilities - Payers and healthcare tech firms using selected analytics or cybersecurity tools ## Geography The company is primarily U.S.-focused, but it also has a presence in Singapore, the UK, and a small number of other countries. International expansion is opportunistic rather than the core growth engine, so geography mainly affects market expansion potential, implementation complexity, and exposure to different healthcare systems. - United States is the core market and main revenue base - Presence in Singapore and the UK supports international expansion - Other countries are limited and opportunistic in scope - Healthcare provider demand outside the U.S. is a growth option - Geography matters because healthcare workflows and regulation differ by market ## Strategy Health Catalyst is focused on simplifying its commercial engine, improving retention, and increasing technology ARR bookings while continuing to invest in Health Catalyst Ignite. Management is also pushing automation, global resources, and AI-enabled solutions to reduce complexity, improve time to value, and strengthen long-term differentiation. - **Strengthen and simplify the commercial engine** (short-term) — Management wants more efficient bookings growth and better conversion in the most differentiated offerings. - **Complete migration to Health Catalyst Ignite** (medium-term) — Migrating legacy DOS clients should improve product relevance and eventually support better gross margin and retention. - **Increase automation and global delivery efficiency** (medium-term) — Lower operating complexity and better use of global resources should improve scalability and time to value. - **Expand AI-enabled and IP-driven solutions** (long-term) — Combining data foundation with expertise and AI can deepen differentiation and support long-term growth. - Grow technology ARR bookings through a stronger commercial engine - Improve retention with more predictable migrations and clearer value realization - Reduce operational complexity through automation and global resources - Invest in Health Catalyst Ignite to modernize the platform - Leverage IP, content, and AI-enabled solutions for higher-value use cases ## Risks The business faces intense competition from analytics vendors, EHR companies, point solutions, and homegrown healthcare systems, which can pressure pricing and slow adoption. It also carries execution risk around client retention, migration from legacy systems, privacy/security of PHI, and goodwill impairment if market value or operating performance weakens. - **Intense competition across healthcare analytics and software** [high] — Clients can choose EHR vendors, niche point solutions, or homegrown tools instead of Health Catalyst's platform. - **Migration execution risk from DOS to Health Catalyst Ignite** [high] — Migration increases technology costs in the near term and can affect gross margin and client satisfaction if delayed. - **Privacy, security, and PHI handling risk** [high] — The company processes sensitive healthcare data and must comply with contractual and regulatory obligations. - **Goodwill impairment risk** [high] — Management recorded material goodwill impairment and further declines in stock price or performance could trigger more charges. - **Healthcare policy and client budget pressure** [medium] — Medicaid and research funding reductions can strain customer budgets and delay purchasing decisions. - Intense competition can pressure pricing and win rates - Client migrations can raise costs and disrupt retention - Healthcare data privacy and PHI security are critical execution risks - Goodwill and acquired intangibles may face impairment if performance weakens - Healthcare policy changes can reduce client budgets and contract demand ## Accounting Revenue comes from technology subscriptions and professional services, so the timing of contract performance and project completion affects quarterly results. Investors should also watch goodwill impairment, contingent consideration from acquisitions, and the impact of migration-related costs on gross margin and adjusted EBITDA. - **Revenue recognition for technology subscriptions and professional services** — Quarterly revenue and margin volatility - **Goodwill impairment** — Large non-cash earnings volatility - **Contingent consideration from acquisitions** — G&A and operating income - **Migration-related technology costs** — Technology gross margin and adjusted EBITDA - Revenue recognition depends on contract obligations and service delivery timing - Technology vs. professional services mix affects margin profile - Goodwill impairment can create large non-cash charges - Contingent consideration from acquisitions can change G&A expense - Migration costs can temporarily depress technology gross margin --- *Last updated: 2026-04-28T20:14:27.555268+00:00*